JPRN-UMIN000015778已完成未知
Study of the effect of tofogliflozin on glucose and lipid metabolism abnormality after the test meal loading. - Study of the effect of tofogliflozin on glucose and lipid metabolism abnormality after the test meal loading.
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1) Patient who had SGLT2 inhibitor with past 2 months. 2) Patient whose concomitant drug had changed with past 2 months. 3) Patient who is diagnosed as contraindication of tofogliflozin. (1) Patient with a history of hypersensitivity to any of the components of the product (2) Patient with a severe ketotic diabetic coma or precoma. (3) Patient with severe infectious disease, before and after operation, and a serious injury. 4) Patient receiving other diabetes drugs. 5) Patient with severe renal disorder (estimated GFR< 30mL/min/1.73m2). 6) Patient with a history of cerebral infarction. 7) Patient receiving diuretic drugs. 8) Patient whom the principle investigator or other investigator consider unsuitable.
研究者
相似试验
尚未招募
不适用
Effect of tofogliflozin on glycemic fluctuation in patients with type 2 diabetes with non-alcoholic fatty liver disease (NAFLD)type 2 diabetesJPRN-UMIN000048523Minami Osaka Hospital24
已完成
不适用
The effect of Tofogliflozin (SGLT2 inhibitor) on endogenous glucose production and insulin clearance.JPRN-jRCTs031180117Tamura Yoshifumi12
招募中
不适用
The effect of SGLT2 inhibitor tofogliflozin on glycemic daily variation by blood glucose using CGMs in patient with type 2 diabetes.JPRN-UMIN000025454Dokkyo Medical University Department of Endocrinology and Metabolism20
未知
1 期
Drug-drug interaction study (2) of TofoglifloziJPRN-jRCT2080221710Chugai Pharmaceutical Co., Ltd.87
已完成
不适用
Effect on Insulin Resistance in Tofogliflozin-treated Japanese Type 2 diabetic patientsType 2 diabetesJPRN-UMIN000017006Matsuba Medical Clinic15